BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11856802)

  • 1. Genes, microbes, and T cells--new therapeutic targets in Crohn's disease.
    Elson CO
    N Engl J Med; 2002 Feb; 346(8):614-6. PubMed ID: 11856802
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic susceptibility and regulation of inflammation in Crohn's disease. Relationship with the innate immune system.
    Peña AS; Peñate M
    Rev Esp Enferm Dig; 2002 Jun; 94(6):351-60. PubMed ID: 12432592
    [No Abstract]   [Full Text] [Related]  

  • 3. Crohn's disease is caused by mutations in the bacterial response protein NOD2.
    Press RD
    Mol Diagn; 2001 Dec; 6(4):347-8. PubMed ID: 11837220
    [No Abstract]   [Full Text] [Related]  

  • 4. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
    Philpott DJ; Viala J
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
    Ogura Y; Bonen DK; Inohara N; Nicolae DL; Chen FF; Ramos R; Britton H; Moran T; Karaliuskas R; Duerr RH; Achkar JP; Brant SR; Bayless TM; Kirschner BS; Hanauer SB; Nuñez G; Cho JH
    Nature; 2001 May; 411(6837):603-6. PubMed ID: 11385577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.
    Watanabe T; Kitani A; Murray PJ; Strober W
    Nat Immunol; 2004 Aug; 5(8):800-8. PubMed ID: 15220916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's disease: genetic susceptibility, bacteria, and innate immunity.
    Van Heel DA; McGovern DP; Jewell DP
    Lancet; 2001 Jun; 357(9272):1902-4. PubMed ID: 11425408
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview: Nod2, cause of, or contributor to, Crohn's disease.
    Punchard NA
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1378-81. PubMed ID: 11890351
    [No Abstract]   [Full Text] [Related]  

  • 9. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NOD2 gene mutation associated with susceptibility to Crohn's disease. Evidence of an alteration with links genetic and environmental factors].
    Gutiérrez-Ruiz MC; Robles-Díaz G
    Rev Invest Clin; 2001; 53(5):386-7. PubMed ID: 11795102
    [No Abstract]   [Full Text] [Related]  

  • 11. [NOD2: A functional and positional candidate gene in Crohn's disease].
    Folwaczny C; Glas J
    Z Gastroenterol; 2002 Mar; 40(3):205-7. PubMed ID: 11901457
    [No Abstract]   [Full Text] [Related]  

  • 12. [From gene to disease; 'frame shift'-mutation in the CARD15-gene and Crohn's disease].
    van der Linde K; Kuipers EJ; de Rooij FW; Wilson JH
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2539-42. PubMed ID: 12532667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of NOD2 gene in Crohn's disease].
    Hugot JP
    Gastroenterol Clin Biol; 2002 Jan; 26(1):13-5. PubMed ID: 11938034
    [No Abstract]   [Full Text] [Related]  

  • 14. How NOD-ing off leads to Crohn disease.
    O'Neill LA
    Nat Immunol; 2004 Aug; 5(8):776-8. PubMed ID: 15282558
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenesis of Crohn's disease in the 21st century.
    Hume G; Radford-Smith GL
    Pathology; 2002 Dec; 34(6):561-7. PubMed ID: 12555995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New targets for Crohn's disease.
    Pestell K
    Trends Pharmacol Sci; 2001 Jul; 22(7):342. PubMed ID: 11431024
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory bowel disease: Crohn's disease and the success of NODern genetics.
    Newman B; Siminovitch K
    Clin Invest Med; 2003 Dec; 26(6):303-14. PubMed ID: 14690304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARD15/NOD2 mutations in Crohn's disease.
    Hugot JP
    Ann N Y Acad Sci; 2006 Aug; 1072():9-18. PubMed ID: 17057186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
    Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
    Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CARD15 and Crohn's disease.
    Peters KE; Cavanaugh JA
    J Gastroenterol Hepatol; 2004 Jul; 19(7):830. PubMed ID: 15209636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.